• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社会经济剥夺增加多发性硬化症患者残疾的风险。

Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients.

机构信息

UNICAEN, CHU de Caen Normandie Department of Neurology, MS Expert Center, Normandie University, Caen 14000, France; Réseau Bas-Normand Pour la Prise en Charge de la SEP, Caen, France.

UNICAEN, CHU de Caen, INSERM U1086 ANTICIPE, Pôle de Recherche, Normandie University, Caen 14000, France.

出版信息

Mult Scler Relat Disord. 2020 May;40:101930. doi: 10.1016/j.msard.2020.101930. Epub 2020 Jan 7.

DOI:10.1016/j.msard.2020.101930
PMID:31982665
Abstract

BACKGROUND

Little is known about the association between the socioeconomic status (SES) and disability risk of patients with Multiple Sclerosis (MS).

OBJECTIVE

The aim of this study was to assess the influence of low SES, otherwise known as socioeconomic deprivation, on the disability risk of MS patients.

METHODS

4498 patients with a relapsing MS disease onset between 1982 and 2017 were included from the databases of three MS expert centres (Caen, Rouen, Lille) of the French Observatory for MS (OFSEP). Sociodemographic and clinical data of 3641 patients were used for the analysis. The EDI (European Deprivation Index), an ecological and composite indicator was used to assess the level of socioeconomic deprivation. Comparisons of time to reach EDSS 4 and EDSS 6, chosen as disability milestones, according to EDI quintiles were performed by Kaplan-Meier analysis. Cox proportional hazard models were also conducted to assess the risk according to EDI quintiles with adjustment to sex, MS type and age at disease onset.

RESULTS

In the study population (n = 3641), most patients were women (71.9%; n = 2664). The mean age at disease onset was 32.2 years (SD =9.7). 1684 (46%) patients reached EDSS 4 and 1005 (28%) reached EDSS 6. The risk of reaching EDSS 4 and EDSS 6 in more socioeconomically deprived patients (EDI Q5) was independently higher than in the less socioeconomically deprived patients (EDI Q1) (HR=1.37 95%CI [1.15-1.64]) to reach EDSS 4 and (HR=1.42 95%CI [1.13-1.75]) to reach EDSS 6.

CONCLUSIONS

In this study, socioeconomic deprivation was significantly associated to the disability risk in MS patients. Better knowledge of socioeconomic disparities in MS may help adapt care to settings and improve the quality of care given to patients in the future.

摘要

背景

人们对社会经济地位(SES)与多发性硬化症(MS)患者残疾风险之间的关系知之甚少。

目的

本研究旨在评估低 SES(也称为社会经济剥夺)对 MS 患者残疾风险的影响。

方法

从法国多发性硬化症观察站(OFSEP)的三个 MS 专家中心(卡昂、鲁昂、里尔)的数据库中纳入了 1982 年至 2017 年间发病的 4498 例复发性 MS 患者。对 3641 例患者的社会人口统计学和临床数据进行了分析。使用 EDI(欧洲剥夺指数)作为评估社会经济剥夺程度的生态和综合指标。通过 Kaplan-Meier 分析比较了根据 EDI 五分位数达到 EDSS 4 和 EDSS 6(选择为残疾里程碑)的时间。还进行了 Cox 比例风险模型分析,以根据 EDI 五分位数评估风险,调整性别、MS 类型和发病年龄。

结果

在研究人群(n=3641)中,大多数患者为女性(71.9%;n=2664)。疾病发病时的平均年龄为 32.2 岁(SD=9.7)。1684 例(46%)患者达到 EDSS 4,1005 例(28%)达到 EDSS 6。社会经济地位较低(EDI Q1)的患者达到 EDSS 4 和 EDSS 6 的风险明显高于社会经济地位较高(EDI Q5)的患者(达到 EDSS 4 的 HR=1.37,95%CI [1.15-1.64])和达到 EDSS 6 的 HR=1.42,95%CI [1.13-1.75])。

结论

在这项研究中,社会经济剥夺与 MS 患者的残疾风险显著相关。更好地了解 MS 中的社会经济差异可能有助于根据环境调整护理,并改善未来患者的护理质量。

相似文献

1
Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients.社会经济剥夺增加多发性硬化症患者残疾的风险。
Mult Scler Relat Disord. 2020 May;40:101930. doi: 10.1016/j.msard.2020.101930. Epub 2020 Jan 7.
2
Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.儿童发病多发性硬化症患者延迟治疗对残疾的长期影响:一项前瞻性丹麦队列研究。
Mult Scler Relat Disord. 2020 May;40:101956. doi: 10.1016/j.msard.2020.101956. Epub 2020 Jan 17.
3
Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.近几十年来多发性硬化症达到残疾里程碑风险的变化:瑞典一项全国范围内基于人群的队列研究。
JAMA Neurol. 2019 Jun 1;76(6):665-671. doi: 10.1001/jamaneurol.2019.0330.
4
Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.光照暴露和对阳光的敏感与多发性硬化症的残疾进展有关。
Mult Scler. 2012 Apr;18(4):451-9. doi: 10.1177/1352458511423778. Epub 2011 Sep 27.
5
The impairment of the functional system and fatigue at the onset of the disease predict reaching disability milestones in relapsing-remitting multiple sclerosis differently in female and male patients.疾病发作时功能系统受损和疲劳会导致女性和男性复发缓解型多发性硬化症患者残疾进展里程碑的出现不同。
Acta Neurol Belg. 2021 Dec;121(6):1699-1706. doi: 10.1007/s13760-020-01478-0. Epub 2020 Sep 30.
6
Long-term disability progression of pediatric-onset multiple sclerosis.儿童发病多发性硬化的长期残疾进展。
Neurology. 2019 Jun 11;92(24):e2764-e2773. doi: 10.1212/WNL.0000000000007647. Epub 2019 May 15.
7
Self-reported levels of education and disability progression in multiple sclerosis.多发性硬化症患者自我报告的教育水平与残疾进展情况
Acta Neurol Scand. 2016 Dec;134(6):414-419. doi: 10.1111/ane.12555. Epub 2016 Jan 6.
8
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.干扰素β治疗与复发缓解型多发性硬化患者残疾进展的相关性。
JAMA. 2012 Jul 18;308(3):247-56. doi: 10.1001/jama.2012.7625.
9
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis.儿童发病多发性硬化症患者持续性残疾的风险。
JAMA Neurol. 2021 Jun 1;78(6):726-735. doi: 10.1001/jamaneurol.2021.1008.
10
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study.社会经济地位对法国多发性硬化症患者超额死亡率的影响:一项回顾性观察队列研究。
Lancet Reg Health Eur. 2022 Nov 17;24:100542. doi: 10.1016/j.lanepe.2022.100542. eCollection 2023 Jan.

引用本文的文献

1
Socioeconomic inequalities in disability prevalence and health service use in Bangladesh.孟加拉国残疾患病率与医疗服务利用方面的社会经济不平等现象。
Sci Rep. 2025 Jul 2;15(1):23363. doi: 10.1038/s41598-025-03173-7.
2
The impact of educational attainment on diagnostic and treatment delays in multiple sclerosis: a nationwide cohort study in Denmark.教育程度对多发性硬化症诊断和治疗延迟的影响:丹麦的一项全国性队列研究。
Ther Adv Neurol Disord. 2025 Feb 14;18:17562864251313918. doi: 10.1177/17562864251313918. eCollection 2025.
3
Stable excess mortality in a multiple sclerosis cohort diagnosed 1970-2010.
稳定的多发性硬化症队列患者超额死亡率,该队列于 1970-2010 年确诊。
Eur J Neurol. 2024 Dec;31(12):e16480. doi: 10.1111/ene.16480. Epub 2024 Sep 11.
4
Associations between socioeconomic inequalities and progression to psychological and cognitive multimorbidities after onset of a physical condition: a multicohort study.身体疾病发作后社会经济不平等与心理和认知多重疾病进展之间的关联:一项多队列研究
EClinicalMedicine. 2024 Jul 25;74:102739. doi: 10.1016/j.eclinm.2024.102739. eCollection 2024 Aug.
5
Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study.早期逆境与儿科多发性硬化症的社会经济因素:病例对照研究。
Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200282. doi: 10.1212/NXI.0000000000200282. Epub 2024 Aug 15.
6
Descriptive Analysis of Health Disparities Between Black and White People With Multiple Sclerosis in the Deep South.美国最南部地区黑人和白人多发性硬化症患者健康差异的描述性分析。
Int J MS Care. 2024 Jul 1;26(Q3):167-173. doi: 10.7224/1537-2073.2023-084. eCollection 2024 May.
7
Prevalence and Burden of Multiple Sclerosis in China, 1990-2019: Findings From the Global Burden of Disease Study 2019.中国 1990-2019 年多发性硬化症的流行和负担:2019 年全球疾病负担研究的结果。
Neurology. 2024 Jun 11;102(11):e209351. doi: 10.1212/WNL.0000000000209351. Epub 2024 May 17.
8
Economic and Social Standing of Individuals in Iran Diagnosed with Multiple Sclerosis.伊朗多发性硬化症患者的经济和社会地位。
Arch Iran Med. 2023 Aug 1;26(8):413-418. doi: 10.34172/aim.2023.63.
9
Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context.普遍医疗保健背景下的发病前社会人口统计学状况与多发性硬化症结局。
JAMA Netw Open. 2023 Sep 5;6(9):e2334675. doi: 10.1001/jamanetworkopen.2023.34675.
10
Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General Neurologist.普通神经科医生对多发性硬化症诊断与治疗的最新进展
J Clin Neurol. 2023 May;19(3):217-229. doi: 10.3988/jcn.2022.0208.